Ferring’s Degarelix Effectively Cut Testosterone Levels In Phase III Prostate Cancer Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
However, more details are needed before clinicians get excited about this drug, one oncologist tells “The Pink Sheet” DAILY.